文献速递胃肠外科

国产图迈®机器人辅助胃肠手术的初步探索性临床研究

An initial exploratory clinical study and outcome assessment of gastrointestinal surgeries using advanced robotic-assisted techniques.
PubMed 文献 · Surg Endosc · 2024-11-21

本研究为前瞻性单中心单臂探索性研究,纳入12例胃切除术和9例结直肠切除术患者,评估国产图迈®腹腔镜手术机器人系统在复杂胃肠手术中的安全性和有效性。结果显示所有手术均成功完成,无中转开腹或腹腔镜,无术中器官损伤、死亡、系统故障或严重术后并发症,初步证明该系统安全有效。

要点

  • 图迈®机器人系统在胃和结直肠手术中手术成功率达100%,无中转。
  • 胃根治术的中位对接时间17.50分钟,主从控制时间121.50分钟,术中出血量100.00 mL,术后住院9.00天。
  • 结直肠根治术的中位对接时间22分钟,主从控制时间68分钟,出血量50 mL,术后住院7天。

核心结论

  • 初步证据支持图迈®腹腔镜手术机器人在胃和结直肠手术中安全有效。

研究设计与样本

  • 前瞻性单中心单臂探索性研究,2022年6月至2023年10月在甘肃省人民医院纳入12例胃切除术和9例结直肠切除术患者。

主要发现

  • 所有患者均成功完成机器人辅助手术,肿瘤学切除充分,术后结果良好。
  • 无中转开腹或腹腔镜手术,手术成功率为100%。
  • 胃根治术:中位对接时间17.50(14.25, 21.50)分钟,主从控制时间121.50(105.50, 172.00)分钟,术中出血量100.00(50.00, 275.00)mL,术后住院9.00(7.25, 10.75)天。
  • 结直肠根治术:中位对接时间22(17.50, 30.50)分钟,主从控制时间68(56.50, 119.00)分钟,出血量50(50.00, 150.00)mL,术后住院7(7.00, 10.00)天。
  • 无术中器官损伤、死亡、系统故障或严重术后并发症报告。

临床怎么用

  • 图迈®机器人系统可作为胃肠手术的可行选择,但需更多研究验证。

局限性

  • 本研究为单中心、单臂、小样本探索性研究,结果需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In addition to the Da Vinci surgical robot, domestic surgical robots are being developed rapidly. Chinese Toumai® laparoscopic surgical robot was approved for urological surgery in 2022.This study aims to systematically evaluate the safety and efficacy of the Toumai® robotic surgical system in performing complex gastrointestinal surgeries. METHODS: This prospective, single-center, single-arm exploratory study was conducted at Gansu Provincial Hospital between June 2022 and October 2023, enrolling 12 patients undergoing gastrectomy and 9 patients undergoing colorectal resection. The primary endpoints are oncological outcomes and surgical success rates, while secondary endpoints encompassed intraoperative blood loss, operative duration, complication rates, system performance metrics, length of hospital stay, and postoperative pain levels. RESULTS: All patients successfully underwent robotic-assisted surgery with adequate oncological resection and favorable postoperative outcomes. There were no conversions to open or laparoscopic surgery, resulting in a 100% procedural success rate. The median docking time for radical gastrectomy was 17.50 (14.25, 21.50) minutes, with a median master-slave control time of 121.50 (105.50, 172.00) minutes, median intraoperative blood loss of 100.00 (50.00, 275.00) mL, and a median postoperative hospital stay of 9.00 (7.25, 10.75) days. For radical colorectal surgery, the median docking time was 22 (17.50, 30.50) minutes, the median master-slave control time was 68 (56.50, 119.00) minutes, with a median blood loss of 50 (50.00, 150.00) mL, and a median postoperative hospital stay of 7 (7.00, 10.00) days. No intraoperative organ injury, mortality, system failure, or severe postoperative complications were reported. CONCLUSIONS: These preliminary findings provide compelling evidence supporting the safety and efficacy of the Toumai® laparoscopic surgical robotic system in performing gastric and colorectal surgeries.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Zhang Z, Zhan W, Tian H, et al. An initial exploratory clinical study and outcome assessment of gastrointestinal surgeries using advanced robotic-assisted techniques. Surg Endosc. 2024. PMID: 39572427. doi:10.1007/s00464-024-11398-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。